Regeneron Pharmaceuticals
An Associate Director of Pathology at Regeneron leads clinical pathology support for drug efficacy and safety studies across various therapeutic areas, including GLP toxicology and pharmacokinetics. The role involves mentoring junior pathologists, interpreting pharmacologic and toxicity findings, and collaborating with internal researchers and CRO partners to advance the pharmaceutical pipeline. A scientific leader is expected to determine clinical pathology endpoints and drive decision-making for nonclinical drug development.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
26% above the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Veterinary Anatomic Pathologist
Eli Lilly and Company
Associate Director, Toxicology, Nonclinical Development (Program Toxicologist)
8a7882525b6027b0015b692822e001ab
Senior or Principal Pathologist
WuXi AppTec
Principal Scientist, Veterinary Pathology Board Certified
Merck & Co., Inc.
Associate Director of Pathology
iSi Environmental
Director/Senior Director, Nonclinical Safety
Nimbus Therapeutics